[go: up one dir, main page]

BRPI0512681A - derivados de uréia cìclica de amino, preparação destes e emprego farmacêutico destes como inibidores de cinase - Google Patents

derivados de uréia cìclica de amino, preparação destes e emprego farmacêutico destes como inibidores de cinase

Info

Publication number
BRPI0512681A
BRPI0512681A BRPI0512681-9A BRPI0512681A BRPI0512681A BR PI0512681 A BRPI0512681 A BR PI0512681A BR PI0512681 A BRPI0512681 A BR PI0512681A BR PI0512681 A BRPI0512681 A BR PI0512681A
Authority
BR
Brazil
Prior art keywords
alkyl
heteroaryl
alkynyl
cycloalkyl
alkenyl
Prior art date
Application number
BRPI0512681-9A
Other languages
English (en)
Inventor
Hartmut Strobel
Sven Ruf
Dominique Lesuisse
Conception Nemecek
Youssef El-Ahmad
Stefan Guessregen
Anne Lebrum
Kurt Ritter
Didier Benard
Augustin Hittinger
Herve Bouchard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34931289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0512681(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BRPI0512681A publication Critical patent/BRPI0512681A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

DERIVADOS DE URéIA CìCLICA DE AMINO, PREPARAçãO DESTES E EMPREGO FARMACêUTICO DESTES COMO INIBIDORES DE CINASE A invenção refere-se a produtos de fórmula (I): em que p = 0,1 e 2; A = arila, heteroarila, carbociclo ou heterociclo; X = ligação única; -N(R)-; - NH-alk-; alquileno; -O-; -S(O)n-: -N(R6)-C(O)-; -NH-CO-alk-; -N(R6)-C(O)- N(R6<39>)-; .-N(R6)-C(S)-N(R6<39>)-; -N(R6)-C(O)O-; -N(R6)-SO2-; -N(R6)-SO2-N(R6<39>)-; -C(O)-N(R6)-; -SO2-NR6-; e -C(O)O-; L1 = ligação única, alquileno, alquenileno, alquinileno, cicloalquileno, fenileno, heteroarileno; todos opcionalmente substituídos: R1 = hidrogênio, alquila, alquenila, alquinila ou cicloalquila, arila, heteroarila, arilalquila, heteroarilalquila; -SO2R9, -C(O)R9; -C(O)OR9, -C(O)NR10R11, -C(S)NR10R11, -SO2NR10R11; R2 = hidrogênio, alquila, alquenila, alquinila, cicloalquila, ou R1 e R2 com N, ou NR1R2 com L1 podem formar heterociclo saturado ou insaturado possivelmente contendo O, N, S; R3 = hidrogênio; halogênio; alquila, alquenila, alquinila, cicloalquila, alcóxi, alquilenodióxi, heterociclo, arila e heteroarila, todos opcionalmente substituídos; S(O)n-alquila, amino, alquilamino, dialquilamino, com dialquilamino opcionalmente formando com N um ciclo, todos opcionalmente substituídos; R4, R4<39> e R4'' = hidrogênio, halogênio, alquila, alquenila, alquinila, cicloalquila, arila, heteroarila, oxo; com dois dentre R4, R4' e R4'' possivelmente formando com C um anel possivelmente contendo O, N ou S; L2 = ligação única, alquileno,alquenileno, alquinileno, cicloalquileno, -O-, -NR7-, -C(O)-, SO2; Y = N-heterociclo possivelmente contendo O, N ou S; R5 = hidrogênio, halogênio, alquila, alquenila, alquinila, cicloalquila, arila, arilalquila, heteroarila, heteroarilalquila; todos estes radicais sendo opcionalmente substituídos, estes produtos sendo em todas formas isoméricas e os sais, como produtos medicinais.
BRPI0512681-9A 2004-07-27 2005-07-25 derivados de uréia cìclica de amino, preparação destes e emprego farmacêutico destes como inibidores de cinase BRPI0512681A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04291904A EP1621536A1 (en) 2004-07-27 2004-07-27 Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
PCT/EP2005/008720 WO2006010641A2 (en) 2004-07-27 2005-07-25 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Publications (1)

Publication Number Publication Date
BRPI0512681A true BRPI0512681A (pt) 2008-04-01

Family

ID=34931289

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512681-9A BRPI0512681A (pt) 2004-07-27 2005-07-25 derivados de uréia cìclica de amino, preparação destes e emprego farmacêutico destes como inibidores de cinase

Country Status (20)

Country Link
US (1) US7759379B2 (pt)
EP (2) EP1621536A1 (pt)
JP (1) JP2008508228A (pt)
KR (1) KR20070038529A (pt)
CN (1) CN101031559A (pt)
AR (1) AR050269A1 (pt)
AT (1) ATE498618T1 (pt)
AU (1) AU2005266460A1 (pt)
BR (1) BRPI0512681A (pt)
CA (1) CA2571323A1 (pt)
DE (1) DE602005026395D1 (pt)
EA (1) EA011088B1 (pt)
IL (1) IL180286A0 (pt)
MA (1) MA28732B1 (pt)
MX (1) MX2007001024A (pt)
NO (1) NO20071067L (pt)
PE (1) PE20060383A1 (pt)
TW (1) TW200616973A (pt)
UY (1) UY29039A1 (pt)
WO (1) WO2006010641A2 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7354933B2 (en) * 2003-01-31 2008-04-08 Aventis Pharma Sa Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621539A1 (en) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621535A1 (en) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
FR2896504B1 (fr) 2006-01-23 2012-07-13 Aventis Pharma Sa Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
FR2896503B1 (fr) * 2006-01-23 2012-07-13 Aventis Pharma Sa Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
PL2368550T3 (pl) 2006-03-27 2014-01-31 Univ California Modulator receptorów androgenowych do leczenia raka gruczołu krokowego i chorób związanych z receptorami androgenów
US8835426B2 (en) * 2007-02-26 2014-09-16 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5470557B2 (ja) * 2007-07-26 2014-04-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
EP2229368A1 (en) 2007-12-11 2010-09-22 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) * 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5734666B2 (ja) * 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤
JP5730021B2 (ja) * 2008-02-15 2015-06-03 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤としてのシクロアルキルラクタム誘導体
CA2718264A1 (en) * 2008-03-18 2009-09-24 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
JP5301563B2 (ja) * 2008-05-01 2013-09-25 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
CA2723034A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723032A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5696037B2 (ja) 2008-05-01 2015-04-08 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
EP2324017B1 (en) 2008-07-25 2014-12-31 Boehringer Ingelheim International GmbH INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
CN104327062A (zh) 2008-07-25 2015-02-04 贝林格尔·英格海姆国际有限公司 11β-羟基类固醇脱氢酶1的环状抑制剂
EP2393807B1 (en) 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
US20100331320A1 (en) * 2009-04-30 2010-12-30 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
US8883778B2 (en) 2009-07-01 2014-11-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
KR20120082906A (ko) 2009-09-30 2012-07-24 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 자가포식현상-향상 유전자 생성물의 조절을 통한 자가포식현상의 조절 방법
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド 置換５、６及び７員複素環、そのような化合物を含有する医薬及びそれらの使用
JP5813106B2 (ja) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝障害の処置のための１１−β−ＨＳＤ１のインヒビターとしてのアザスピロヘキサノン
PH12013500808A1 (en) 2010-11-02 2015-10-07 Boehringer Ingelheim Int Pharmaceutical combinations for the treatment of metabolic disorders
PE20150765A1 (es) 2012-09-26 2015-05-15 Aragon Pharmaceuticals Inc Antiandrogenos para el tratamiento del cancer de prostata resistente a la castracion no metastasico
CA3220371A1 (en) * 2014-09-29 2016-04-07 Chemocentryx, Inc. Processes and intermediates in the preparation of c5ar antagonists
AU2019387367A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Diarylhydantoin compounds and methods of use thereof
WO2021057696A1 (zh) * 2019-09-27 2021-04-01 隆泰申医药科技(南京)有限公司 一种杂芳基类化合物及其应用
WO2022206583A1 (zh) * 2021-03-29 2022-10-06 浙江大学 吲唑类化合物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476087A1 (fr) 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2671348B1 (fr) 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
DE19540027A1 (de) * 1995-10-27 1997-04-30 Gruenenthal Gmbh Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
FR2796945B1 (fr) * 1999-07-30 2002-06-28 Sod Conseils Rech Applic Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
US6114365A (en) * 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
AU2002951247A0 (en) * 2002-09-06 2002-09-19 Alchemia Limited Compounds that interact with kinases
US7354933B2 (en) * 2003-01-31 2008-04-08 Aventis Pharma Sa Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
FR2850652B1 (fr) * 2003-01-31 2008-05-30 Aventis Pharma Sa Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
US7256208B2 (en) 2003-11-13 2007-08-14 Bristol-Myers Squibb Company Monocyclic N-Aryl hydantoin modulators of androgen receptor function
EP1621535A1 (en) 2004-07-27 2006-02-01 Aventis Pharma S.A. Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621539A1 (en) 2004-07-27 2006-02-01 Aventis Pharma S.A. Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Also Published As

Publication number Publication date
NO20071067L (no) 2007-04-26
ATE498618T1 (de) 2011-03-15
JP2008508228A (ja) 2008-03-21
AR050269A1 (es) 2006-10-11
EP1621536A1 (en) 2006-02-01
WO2006010641A2 (en) 2006-02-02
EA200700141A1 (ru) 2007-08-31
CN101031559A (zh) 2007-09-05
TW200616973A (en) 2006-06-01
EP1773808A2 (en) 2007-04-18
US7759379B2 (en) 2010-07-20
AU2005266460A1 (en) 2006-02-02
PE20060383A1 (es) 2006-06-06
KR20070038529A (ko) 2007-04-10
EP1773808B1 (en) 2011-02-16
MX2007001024A (es) 2007-04-16
WO2006010641A3 (en) 2006-10-26
CA2571323A1 (en) 2006-01-02
UY29039A1 (es) 2006-02-24
DE602005026395D1 (de) 2011-03-31
EA011088B1 (ru) 2008-12-30
US20080004300A1 (en) 2008-01-03
IL180286A0 (en) 2007-07-04
MA28732B1 (fr) 2007-07-02

Similar Documents

Publication Publication Date Title
BRPI0512681A (pt) derivados de uréia cìclica de amino, preparação destes e emprego farmacêutico destes como inibidores de cinase
PE20070115A1 (es) Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas
TW200617002A (en) Novel substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
BRPI0610030B8 (pt) Composto, composição farmacêutica, e, uso de um composto
PE20060479A1 (es) Compuestos heteroaril-aril-ureas como inhibidores de la quinasa
AR038863A1 (es) Uso de un inhibidor de garft y/o de aicarft y de un agente antitoxico para preparar un medicamento para destruir selectivamente celulas mtap-deficientes de un mamifero
BRPI0407741B8 (pt) pirimidinas e triazinas de inibição de replicação de hiv
PE20020366A1 (es) Derivados de piperazina como ligandos del receptor 5ht2
AR047496A1 (es) Derivados de diaril-urea en el tratamiento de enfermedades dependientes de la quinasa de proteina
UY26957A1 (es) Nuevos agentes anticolinérgicos que se pueden emplear como medicamentos así como procedimiento para su preparación
AR037647A1 (es) Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
EA200600480A1 (ru) Имидазопиридинзамещённые тропановые производные, обладающие активностью антагониста ccr5 рецептора, для лечения вируса иммунодефицита человека (вич) и воспаления
ECSP066948A (es) Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias
UY27752A1 (es) Derivados del tropano útiles en terapia
UY27592A1 (es) Nuevo uso
BRPI0408767A (pt) inibidores de transcriptase reversa não-nucleosìdeos i para o tratamento de doenças mediadas pelo hiv
AR053109A1 (es) DERIVADOS DE PIPERIDINA Y PIPERAZINA, UN METODO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU USO EN LA ELABORACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR EL RECEPTOR DE QUIMIOQUINA CCR2.
BR0307894A (pt) Heterocìclos tricìclicos fundidos úteis para o tratamento de distúrbios hiperproliferativos
UY28377A1 (es) Agentes terapeuticos
AR039111A1 (es) Tiopirimidinas e isotiazolpirimidinas inhibidoras de quinasas
AR059490A1 (es) Cmpuestos antivirales heterociclicos
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
AR054102A1 (es) Derivados de fenil-piperazina-metanona. procesos de obtencion y composiciones farmaceuticas
PE20010485A1 (es) Derivados de bencimidazol sustituidos con aminocarbonilo, procedimiento para su preparacion y su utilizacion como medicamentos
DE60037888D1 (de) Piperazinderivate als aktivitätsmodulatoren der chemokinrezeptoren

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.